Sponsors Platinum

30 Sept – 2 Oct 2013. The Square, Brussels efibforum.com

Europe’s Leading Event for the biobased economy

policy

biomaterials

innovate

connect

100 fEaturEd Industry ExpErts

BOOk NOW

JoIn ovEr 1,000 bIotEchnoLogy profEssIonaLs

6th Annual

business

The European Forum for Industrial Biotechnology & the Biobased Economy

“EFIB has grown year on year to

become the most important event on the

calendar for the biobased economy”

Ian hudson,dupont

Sponsors

Platinum

Gold

Silver

Bronze

Preferred Airline Taking place during

Exhibitors

Supporting Partners

Plenary Speakers

SPECIALSPonge Enzymes and Cells for Innovative AppLications

Online: efibforum.com Call +44 (0)1372 802 052Book NoW

EuropaBio and Smithers Rapra have captured the momentum of European Forum for Industrial Biotechnology (EFIB) 2012 and are now bringing you their biggest and most ambitious congress to date. Taking place from 30 September to 2

October at the prestigious SQUARE, Brussels, in

association with bio.be, EFIB 2013 has transformed

to become the premier marketplace for the

European biobased economy. The return

to Brussels represents an excellent

opportunity to increase engagement

between industry, policy makers and

stakeholders and aims to attract over

1,000 stakeholders from across the

biobased economy. This unmissable event

is a must for all those wanting to take part in

defining, developing and shaping this burgeoning

smart and sustainable sector.

Continuing its theme; business meets policy, this

year’s conference agenda brings together a host

of high-profile policy keynote speakers, industry’s

leading CEOs, finance and market analysts and

visionary innovators.

The success of constructing a dynamic and

competitive European biobased economy requires

the full support and engagement of EU and

national decision makers and continues to be

an important area for discussion. This

year, one key focus area will be the

Public Private Partnerships (PPP),

for biobased industries, developed

under the European Commission’s

new framework for Research

and Innovation, Horizon 2020.

This and other initiatives

have the potential to

help bridge the EU’s

innovation valley of

death between scientific excellence

and successful commercialisation

and uptake of sustainable biobased

products, processes and solutions. With

this in mind, the EFIB conference programme

brings together the thought leaders at the forefront

of this framework development from a broad range

of disciplines and sectors to discuss how these, and

other new measures will impact the European

biobased economy.

Join us this year for an insight into this

exciting and rapidly evolving landscape

and be part of the process of building

a stronger more sustainable biobased

economy.

Overview of the EFIB Theme: Business meets Policy

The business meets policy theme runs throughout

this year’s conference agenda, from the opening

plenary keynotes by Belgium’s Prime Minister,

Elio di Rupo, to the perspectives from European

Commission and Parliament decision makers, to

international policy perspectives from the Americas

and Asia. Insights from the worlds of finance and

technology will be provided through a track on

venture capital financing and the ever popular

innovation track, showcasing technology and

product breakthroughs in the biobased economy.

This year’s business meets policy debate

features leading CEOs and Managing

Board Members from Novozymes,

DSM and SME Proviron as well

as influential policymakers to

analyse whether the EU has

what it takes to make the

transition towards a biobased

economy.

“Great meeting opportunities”

camille burel, roquette

The European Forum for Industrial Biotechnology is evolving…

“Organised behind the scenes so the industry,

speakers and attendees can relax and focus on

what matters” sarah hickingbottom,

LMc International


30 Sept – 2 Oct 2013 The Square, Brussels

Europe’s Leading Event for the biobased economy efibforum.com

“The biobased economy represents a great opportunity for Europe and EFIB plays an important role in

combining business and policy to harness the

opportunity”Lars hansen, novozymes

“Bringing together policy, industry and

the whole value chain. EFIB is the event in the

biotech calendar.”Kathryn sheridan,

sustainability consult

Top reasons to attend EFIB 2013Who should attend?EFIB is designed for the entire biobased industries supply chain enabled by Industrial Biotechnology and is THE must attend event in Europe for:

z CEOs, MDs and Strategy, Business Development, Marketing and Sales Directors from biochemical companies and feed stocks suppliers

z Policy makers, government officials, regulators and compliance officers

z Academics, research institutes, R&D Professionals and working groups

z Directors of Industrial Biotechnology, Sustainability, VPs and CEOs from start-ups and SMEs

z Analysts, Investors and Consultants with an interest in IB

z Buyers interested in finding new IB applications for industrial use

z Media and NGOs with an interest in the biobased economy

What happened at EFIB 2012? z 500 delegates in attendance

z Over 1,000 partnering meetings booked and attended

z 80 speakers in 8 dedicated sessions over two days across business and policy.

z Commissioners and national ministers as well as CEO’s from leading biotech companies featured on the programme.

z Highlights included the CEO panel, the Commissioners address and the partnership sessions.

z Delegates in 2012 represented 28 different countries across the world

z 50% of attendees were Board-level, C-level, Founders, Directors, Presidents and VP’s

z Attendee growth of over 200% since launch event in 2008

GlobalSpeaker Expertise

belgiumbrazilchina

denmarkfinlandfrance

germanyItaly

LuxembourgMalaysia

netherlandsportugalrussia

swedenswitzerland

united Kingdomusa

Be there for the keynote welcome address from Belgium’s Prime Minister, Elio di Rupo

Hear industry keynotes from CEOs of Ecover and Galactic and their different experiences doing business within the European biobased economy

Learn the latest on the EU’s Research and Innovation Strategy and what’s in store for biobased industries from leading policy makers

Discuss market uptake of biobased products in the Market Pull Panel, featuring Daniel Calleja Crespo, Director-General of DG Enterprise and a host of leading consumer brands

Interact with key policy makers and visionary industry leaders in the business meets policy debate, examining whether the EU has what it takes to pull together to create a world leading biobased marketplace

Choose the agenda to suit you with 8 dedicated conference sessions focused on policy, finance, innovation and BRIDGE; the EU’s €3.8 billion proposal for a Public Private Partnership for biobased industries

Be the first to witness the latest innovations and product development at the NEW Technology Showcase in the Exhibition Hall

Take part in CEO Question Time and put your questions to those in strategic positions to move the industry forward

Visit over 50 exhibitors and see for yourself first-hand what the European and wider industrial biotechnology industry has to offer

Enhance your networking experience with numerous opportunities to interact with fellow delegates at the welcome drinks reception and the EFIB Gala Social Evening taking place at an exclusive location in Brussels city centre

Take advantage of the 1-to-1 Partnering at EFIB to make efficient use of your networking time, during over 14 hours of active partnering sessions.


Workshop 1: the Wood-based bioeconomy

Market potential, business opportunities and new product innovations for the wider industry

9:30 Registration

10:00 Welcome and introduction to the renewed Strategic Research and Innovation Agenda of the forest-based sectorJohan Elvnert, Managing Director, Forest Technology Platform

10:20 New business opportunities in the Wood-based BioeconomyDr. Niklas von Weymarn, Vice President, Metsä Fibre

10:40 Why the climate benefits from building with wood?Kimmo Järvinen Secretary General, European Organization of the Sawmill Industry

11:00 Panel discussion – is there enough raw material for everyone?

11:15 Refreshment break

11:45 Potential of biotechnology in wood biorefiningJohanna Buchert, Vice President, VTT

12:05 New fibres and green chemicals for traditional marketsGudbrand Rødsrud, Technology Director, Borregaard

12:25 Closing panel discussion Promising markets, promising products

12:45 Close of workshop

Workshop 2: Marine biotechnology

Streaming Marine Biotechnology into business - overcoming bottlenecks and generating innovation

14:15 Registration

14:45 Welcome from Session Chair: Support and exploitation landscape and trends for Marine BiotechnologyMeredith Lloyd-Evans, Managing Director, BioBridge Ltd

15:00 Title tbcAndrew Mearns Spragg, Chief Technology Officer & Founder, Aquapharm, PharmaSea Project

15:15 The role of IT and genomics innovation for industrial use of marine bioresources Renzo Kottman, Scientist, Max Planck Institute for Marine Microbiology, MicroB3 Project

15:30 SeaBioTech and its targets for MBt-to-industry flowIan Fotheringham, President, Ingenza, SeaBioTech Project

15:45 Refreshment break

16:15 BlueGenics: Exploiting marine genomics for an innovative and sustainable European blue biotechnology industryBruno Ferreira, CEO, Biotrend, BlueGenics Project

16:30 Title tbcMike Cowling, Chief Scientist, The Crown Estate

16:45 Using marine genetic resources for commercial activity and possible challenges according to the development of new regimes Thomas Greiber, Senior Legal Officer, International Union for Conservation of Nature

17:00 Q&A: Speaker Panel

17:30 Close of workshop

Monday 30 SeptemberWorkshops

“The quality of EFIB’s attendance and partnering

programme drives collaboration across the value

chain and as such will be instrumental in enabling us to deliver on the promise of the

biobased economy”stephan tanda,

dsM

17:30 Join us early at the welcome drinks reception to meet speakers and delegates and preview

the exhibition area before the conference begins the following morning.

1-to-1 partnering will also be open at this time

BOOk to attend the ever popular

pre-conference workshops at just

€480 each




Ian Hudson, President EMEA, DuPont de Nemours International

Joanna Dupont-Inglis, Director Industrial Biotechnology, EuropaBio

Babette Pettersen, Chief Commercial Officer, BioAmber

Lars Hansen, President of Novozymes, Europe Region, Novozymes

Professor Andre Koltermann, Corporate Research and Development, Clariant

Dr Dirk Carrez, Managing Director, Clever Consult

Catia Bastioli, CEO, Novamont

Dr Niklas von Weymarn, VP Research, Metsa Fibre

Stephan Tanda, Managing Board Member, DSM

Christian Patermann, Independent Consultant

Dr Manfred Kircher, Chairman of the Advisory Board, CLIB2021

Cathy Plasman, Secretary General, bio.be/Essenscia

Dr Jos B. Peeters, Managing Partner, Capricorn Venture Partners

8.00 Coffee & Registration

official EfIb opening plenarysponsored by Iar

Session chair: Nathalie Moll, Secretary General, EuropaBio

9.00 Opening remarksJoanna Dupont-Inglis, Director, Industrial Biotechnology, EuropaBio

9.05 Official welcome address Elio di Rupo, Prime Minister of Belgium

9.15 EU Policy keynoteRudolf Strohmeier, Deputy Director General, DG Research, and Innovation plus EFIB video address from Commissioner Maire Geoghegan-Quinn

9.30 Research and Innovation Funding Programme Horizon 2020 and the development of a Bioeconomy in EuropeMaria da Graça Carvalho, Member of Industry, Research and Energy (ITRE) Committee of European Parliament, Rapporteur for the implemention of Horizon 2020

9.45 Europe versus rest of the world as a launching platform for a white biotech companyFrederic van Gansberghe, CEO, Galactic

10.05 Application of biotechnology and the consumer response to biobased materials in home carePhilip Malmberg, CEO, Ecover

10.25 Morning refreshments in the exhibition hall and partnering

partnerships and End user perspectives in the biobased Economy - sponsored by gEa

11.15 Opening remarks from ChairIan Hudson, President EMEA, DuPont

11.20 The Plant PET Technology CollaborativeVirginie Helias, Director of Global Sustainability, Owe Rehbein, Associate Director Purchases, P&G and Massimo Zonca, Group Leader- Global Packaging, Heinz

11.45 Market Pull Panel: boosting market uptake of biobased products Daniel Calleja Crespo. Director-General of the Enterprise and Industry Directorate-General will be joined by high level representatives from leading end user companies, including car manufacturer Audi, to discuss market uptake of biobased products from a consumer, policy and industry perspective and the rationale for B2C companies to increase use of biobased materials, in relation to their sustainability agendas.

12.45 Lunch, sponsored by GEA, will be served for all speakers and full access delegates in the exhibition hall

Tuesday 1 October – Conference DAY ONE

Conference Programme

EFIB Advisory Board Members


Innovation track: technological breakthroughssponsored by biocatalysts

Introduction from Session ChairStuart West, Managing Director, Biocatalysts

New advances that enable the cellulosic economyFloris Luger, Vice President for Business Development Accellerase, DuPont Industrial Biosciences

Commercialisation of yeast technology for biofuel and biochemical productionDr. Gunter Festel, CEO, Butalco GmbH

Rational Enzyme Mining: An Innovative technique for tapping into the microbial world of novel biocatalystsMartin Karlsson, PhD, COO, Rational Enzyme Mining AB

Novel approaches for metabolic engineering of fungi towards cost effective production of building block chemicals Peter J Punt, TNO Microbiology & Systems Biology

Innovation track: new production processes for Innovative biobased products – part 1

sponsored by biocatalysts

Introduction from Session Chair: Samhitha Udupa, Analyst, Lux Research

Tailor-made biosurfactants through metabolic engineeringProf. Wim Soetaert, Director, Bio Base Europe Pilot Plant

Cellulosic ethanol: Scale-up and commercializationProf. Dr. Andre Koltermann, Clariant

Transition from a traditional chemical producer to a developer of renewable based solutions: a case studyWim Michiels, CEO, Proviron

Biobased product innovations at DSM: a case studyMarcel Lubben, Vice President Bio-based Chemicals & Materials, DSM

Consolidated bioprocessing of lignocellulose to lactic acidDr. Albrecht Läufer, Vice President BU Lignocellulose Conversion, DIREVO Industrial Biotechnology GmbH

Q&A

18.00 Close of conference day one and social evening – details to be announced

sustainable and competitive feedstocks

Introduction from Session ChairJohn Williams, Materials Director, NNFCC

EU Agricultural Policy and implications for the industrial biotech sectorPekka Pesonen, Secretary General, Copa Cogeca

Developments in biomass potentialMichael Carus, CEO, nova-institut

Reconciling competing uses of biomassOlivier Dubois, Climate Change and Bioenergy Unit, FAO – invited

Q&A panel

International policy

Introduction from Session Chair: Dr Antonio di Guilio, Acting Director,Directorate for Biotechnologies, Agriculture, FoodDG Research & Innovation, European Commission

US policy perspectiveBrent Erikson, Executive Vice President, Industry and Environment, BIO

Chinese policy perspectiveProfessor Runlin Ma, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences

Malaysian policy perspectiveDr. Nazlee Kamal, CEO, Malaysian Biotech Corporation

Brazilian policy perspectiveSpeaker invited

Panel discussion

Closing remarks

14.15

14.20

14.40

15.00

15.20

15.40

16.30

16.35

16.50

17.05

17.20

17.35

17.50

Afternoon refreshments in the exhibition hall




8.15 Coffee and new registrations

financing track

Introduction from Session Chair: Dr Jos Peeters, Managing Partner, Capricorn Venture Partners

European Investment trends and evaluation of finance available for biobased industriesGunnar Muent, Head of Department, Projects Directorate, EIB

Venture Capital for the biobased economy Dr Jos Peeters, Managing Partner, Capricorn Venture Partners

Corporate venture investing at BASFDr Richard Riggs, Investment Manager, BASF Venture Capital

Q&A session

session on brIdgE – a ppp on biobased industries

Introduction from Session Chair: Marcel Wubbolts, Chief Technology Officer, DSM Innovation Center

European Commission perspective on BRIDGEBarend Verachtert, Acting Head of Unit Biotechnologies, European Commission, DG Research & Innovation

Member state perspective on the PPP for biobased industriesSpeaker invited

Round table discussion

End of session

9.00

9.05

9.25

9.45

10.05

10.25

11.15

11.20

11.35

11.50

12.05

Wednesday 2 October – Conference DAY TWO

Innovation track: new production processes and collaborations for biobased products – part 2

Introduction from Session Chair: Cathy Plasman, Secretary General, essenscia/Bio.be

Epicerol®: A breakthrough in epichlorohydrin production Thibaud Caulier, Strategic Marketing & Business Development Manager, Solvay S.A.

Supply chain integration to accelerate commercialization of biobased materialsBabette Pettersen, CCO, BioAmber, & Laurence Dufrancatel, Automotive Industry Raw Materials & Processes Innovation Group Leader, Faurecia Interior Systems

Novamont collaboration case studyStefano Facco, New Business Development, Novamont

Cooperation of small and big – A successful case study Marc Struhalla, Managing Partner, c-LEcta and Anders Espe Kristensen, Business Development & Marketing Director, Food & Beverages, Novozymes

Innovation track: Innovative tools in the biobased Economy

Introduction from Session ChairRaphael Hannoir, Business Development Director, Chemicals & Bio-Industries, SNC-Lavalin

Insects, efficient and innovating biomass upgraderAntoine Hubert, Founding Partner / R&D leader, Ynsect

Intensification of bioprocesses: increased performance with less costsDr Florian Graichen, Business Development Manager, Industrial Innovation/Separation and Conversion Technologies, VITO NV

From Variable Biomass Hydrolysates to pure and consistent cellulosic sugars: An innovative process design to close the gapThibault Lesaffre, Bioindustries Market Director, Novasep Process

Open innovation platforms on sugars, fatty acids and proteins: developing the future high-value products biorefineriesJohan De Coninck, Business Development Manager, IAR

Morning refreshments in the exhibition hall

Conference Programme


12.20 Lunch will be served for all speakers and full access delegates

Wednesday 2 October – Conference DAY TWO

EfIb closing plenarysponsored by novozymes

13.50 Introduction from the Chair Jacki Davis, Managing Director, Meade Davis Communications

13.55 Challenges of a biobased economy and the need for building a sustainable supply chainJack Huttner, President and CEO, Huttner Strategies LLC

14.15 Breakthrough collaboration to be unveiledWatch this space…

14.35 the business meets policy debate Mind the gap - can the EU pull together to create a world leading biobased marketplace?

Is Europe culturally ready for the bioeconomy to really thrive? Are we pulling in the same direction or not? Are we in the right mindset to make it happen?

Participants include: z Peder Holk Nielsen, CEO, Novozymes - invited z Stephan Tanda, Managing Board Member, DSM z Wim Michiels, CEO, Proviron z Bas Eickhout, Member of the European Parliament z Philippe de Backer, Member of the European Parliament z Maive Rute, European Commission, Biotechnologies,

Agriculture and Food Directorate, DG Research and Innovation

z Jim Philp, Science and Technology Policy Analyst, OECD z Rogier Van der Sande, Rapporteur, Bioeconomy Strategy,

Committee of the Regions

Moderator: Jacki Davis, Managing Director, Meade Davis Communications

15.50 Closing remarks and presentation of John Sime Award

16.00 Close of conference

EuropaBio is the European Association for Bioindustries and was created in 1996 to provide a voice for the biotech industry at the EU level. EuropaBio’s mission is to promote an innovative and dynamic biotechnology-based industry in Europe.

Smithers Rapra is the world leader in rubber, plastics, polymer and composites expertise. They have been delivering market leading events for the biobased economy for more than a decade. Their global portfolio of events includes more than 10 leading industry conferences on biomaterials, polymer technologies, sustainability and novel materials. The information business also provides member benefits, market forecasts and analysis.

bio.be The Belgian Association for Bioindustries represents the companies and professionals involved in research, development, testing, production or marketing of biotechnology applications, as well as those servicing the biotechnology community.

About the EFIB Organisers

“Very well organised

…many important stakeholders on a

high level” anton glieder,

acIb

Conference programme and speakers subject to change without notice. Please visit efibforum.com for current updates.




Time Tuesday 1st October

10.45-11.00 Delivering integrated process development & proof of concept

testing at scale, Steve Pearson, CPI

11.15-11.30 New DNA Assembly Technology to Accelerate Pathway Development

Tim Gallagher, Genabler

11.45-12.00 GAIA Bioeconomy Tool for Assessing the Sustainability of Emerging Bioeconomy

Tiina Pursula, and Päivi Luoma, Gaia Consulting

12.15-12.30 Engineering enzymes: from identification to optimization

Danny Duijsings, Baseclear BV

13.00-14.00 BiotechCorp Showcase

14.15-14.30 Assessing feedstocks variability in biorefineries

Mathieu Tournat, Soufflet

14.45-15.00 Session available


15.45-16.00 Walloon Minister speech

16.15-16.30 CEO questions – tbc




Time Wednesday 2nd October







For 2013 the EFIB exhibition has grown to be the largest ever, with over 50 exhibitors showcasing their latest product innovations. Plus, new this year, is the Showcase Theatre, which will play host to CEO Question Time, regional policy addresses and an additional chance to hear about new technologies and developments in the biobased economy.

Also taking place in the exhibition hall, 1-to-1 Partnering* sponsored by

Partnering at EFIB 2013 offers a dedicated service to build a personal event experience & networking agenda, only delegates registered with a full access EFIB 2013 pass are entitled to use 1-to-1 partnering.

Partnering at EFIB 2013 offers you the chance to: z Create and arrange your personal event agenda at

EFIB including;• conference sessions• networking activities• private meetings

z Promote your organisation by publishing a dedicated profile to the event community

z Screen the event community for business candidates and networking partners with the help of a dedicated search engine

z Communicate directly with other participants with the help of the online communication centre

z Invite other participants to private 1-to-1 meetings prior to the event

The dedicated Partnering Zone at EFIB 2013 offers all registered delegates, with full EFIB access, who have pre-booked meetings, a comfortable and suitable setting to hold one-to-one meetings. A dedicated partnering staff member will be available in the Partnering Zone at all times to assist you.

More than just a conference…

*only available with an EFIB full access pass

1

2

3

4

5

67

8

9

10

11

26

27

28

29

3031 32

33

34

35

36

37

3839

40

41

42

43

4445

46

47

48

49

50

51

52

53

54

25

24

2322

20

21

12

1314

1516

17

18

19

ES

Attend the EFIB Marketplace for just €99If you’re looking just to attend EFIB’s growing exhibition hall and market place this year then why not pick up a €99 ticket to attend EFIB as Exhibition Only Access. Although the ticket doesn’t give you access to the high-profile business and policy leaders presenting on the conference programme or the 1-to-1 partnering, for just €99 you will have access to the market place exhibition hall, featuring over 50 exhibitors and the 2 day programme at the Showcase Theatre. The perfect place for network and learn about the latest products and innovations in the industry.

Want to be part of the Showcase Theatre in the Exhibition Hall at EFIB 2013?New for this year, the Showcase Theatre runs over 2 days, and is open to all attendees, making this the ideal platform to present your new company, your latest innovation, or your new product development.

Contact Stacey Ludlow today for more details on +44(0)1372 802052 or email [email protected]

Showcase Theatre Agenda


1

2

3

4

5

67

8

9

10

11

26

27

28

29

3031 32

33

34

35

36

37

3839

40

41

42

43

4445

46

47

48

49

50

51

52

53

54

25

24

2322

20

21

12

1314

1516

17

18

19

ES

stand company

1

2

3 Biocatalysts

4

5

6 Europabio

7 Smithers Rapra

8 Media

9 Bio Base Europe

10 CIB / hessen Trade

& Invest

11

12

13

14

15 SNC LAVALIN

16 c-Lecta

17 GEA

18

19

stand company

20

21 CPI

22 Industrial Biotech

Network Norway

23

24

25

26 LMC International

27 Sustainability

Consult

28 Base Clear

29

30

31

32

33 Nova Institute

34 Bio.be

35 Essenscia Flanders

Essenscia Walonnia

36

stand company

37

38

39 State of Iowa

40 IAR

41 BiotechCorp

42 Greenwin

43 FlanderBio Ghent

Bio Energy valley

44 Edinburgh University

45

46 SPECIAL project

47

48

49

50

51

52

53

54

Don’t miss out on

Business Partnering

at EFIB 2013

RESERVED

RESERVED

RESERVEDRESERVED

RESERVED

RESERVED

RESERVED

RESERVEDRESERVED

RESERVEDRESERVED

RESERVEDRESERVEDRESERVED

“Best event to understand progress

in biomaterials”

alain Jacques, colgate-palmolive




Brussels is the thriving centre of Europe, and SQUARE - Brussels Meeting Centre, is right in the heart of it. SQUARE is situated in front of the Central Station, handy for the international airport and train connections.

SQUARE is housed in the extensive former Palais des Congrés, an elegant, architecturally significant building originally constructed for the 1958 World Expo. With its spectacular views over the Brussels skyline, SQUARE is somewhere to inspire the mind to greater heights and ambition.

To find out more about the conference venue, please visit the SQUARE website www.square-brussels.com

AddressSQUARE - BRUSSELS MEETING CENTREGlass Entrance, rue Mont des Arts,B-1000 Brussels Tel +32 2 515 13 18 Fax +32 2 515 13 20 www.square-brussels.com

Travel information

is pleased to be our preferred carrier and extends 10% discount on available economy fares from Europe, Tel Aviv, Moscow, New York & Washington to Brussels.

Go to www.brusselsairlines.com, and after having chosen your dates and cities of departure and destination, click the option “I have a promo code”. Type EFIBFORUM in the box displayed.

You can book until 29 September and travel from 26 September through to 5 November 2013.

How to book your accommodation

Speakers and delegates are responsible for booking their own travel and accommodation. A

limited number of rooms have been reserved for speakers and delegates wishing to stay nearby SQUARE. We recommend rooms are to be reserved no later than 29 August to take advantage of the best negotiated rates.

To reserve your room please contact Conference Initiatives quoting “EFIB2013” at the time of booking:Tel: +44 (0)1483 520101Email: [email protected]/booking/events/efib-2013

PricingPricing for EFIB 2013 is phased. There are great deals to be had if you register early for the 2 day conference. There are also workshop, exhibition and sponsorship packages available.

Visit www.efibforum.com/pricing.aspx for more details.

+44 (0)1372 802052Or online

efibforum.com

BOOk NOW

Attend for FREEdon’t forget that smithers rapra biomaterials

Members have 3 registrations to EfIb 2013 and other smithers rapra biomaterials events!

Not sure if you’re a member or want more information about the many benefits of membership, including access to e-books, online publications, personalized

research assistance for your biomaterials questions and more?

Call +44(0)1372 802000

Location

Full Access PricesEARly BIRD

Valid until 26 July €1099

StAnDARD FEE Valid until 12 September

€1149

lAtE FEE from 13 September

€1199

Full Access Pass includes:

z Welcome Drinks Reception z All refreshment breaks z Conference Lunches z EFIB Gala Social Evening z 2 plenary sessions z 8 conference tracks z 1-to-1 Partnering at EFIB z Full access to post-event proceedings

PLUS: exhibition hall access and showcase theatre presentations

Sponsors Platinum

Documents